Abbott India says to comply with government order on drugs ban
India banned 344 drug combinations after a govt panel of experts found they had 'no therapeutic justification'
 "Abbott India says to comply with government order on drugs ban")
US pharmaceutical giant Abbott Laboratories' India unit will comply with all legal requirements of a government order that bans more than 300 combination drugs in the country, a company spokesman said on Monday.
India banned 344 drug combinations over the weekend, including Abbott's codeine-based cough syrup, after a government panel of experts found they had "no therapeutic justification."
Abbott's Phensedyl cough syrup accounts for about a third of the Indian cough syrup market, and its sales are estimated to make up more than 3% of the company's $1 billion India revenue.